What Kind of Pancreatic Extracts To Use?

  • I. Vantini
  • L. Benini
  • S. Caliari
  • A. Fioretta
Conference paper

Abstract

Treatment of exocrine pancreatic insufficiency is based on oral administration of pancreatic enzyme-containing preparations. The aim is to prevent or correct malnutrition secondary to exocrine pancreatic insufficiency through a clinically relevant reduction or normalization of faecal fat and nitrogen losses.

Keywords

Cystic Fibrosis Chronic Pancreatitis Enzyme Replacement Therapy Pancreatic Enzyme Pancreatic Insufficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Regan PT, Malagelada JR, Di Magno EP, Glanzman SL, Go VLW (1979) Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 297:854– 858CrossRefGoogle Scholar
  2. 2.
    Caliari S, Benini L, Bonfante F, Brentegani MT, Fioretta A, Vantini I (1993) Pancreatic extracts are necessary for the absorption of elemental and polymeric diets in severe pancreatic insufficiency. Scand J Gastroenterol 28:749–752PubMedCrossRefGoogle Scholar
  3. 3.
    Abrams CK, Hamosh M, Dutta SK, Hubbard VS, Hamosh P (1987) Role of nonpancreatic lipolytic activity in exocrine pancreatic insufficiency. Gastroenterology 92:125–129PubMedGoogle Scholar
  4. 4.
    Graham DJ (1972) Enzyme replacement therapy of exocrine pancreatic insufficiency. N Engl J Med 296:1314–1317CrossRefGoogle Scholar
  5. 5.
    Mariani A, Bocchia P, Basilico M, Malesci A (1992) Efficacy of a new pancreatic extract in the treatment of steatorrhea due to chronic pancreatitis. Ital J Gastroenterol 24:164Google Scholar
  6. 6.
    Dobrilla G (1989) Management of chronic pancreatitis. Focus on enzyme replacement therapy. Int J Pancreatol 5:17– 29PubMedGoogle Scholar
  7. 7.
    Marotta F, O’Keefe SJ, Marks IN, Girdwood A, Young G (1989) Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2 antagonists and enteric-coating. Dig Dis Sci 3:456 – 461CrossRefGoogle Scholar
  8. 8.
    Linehan JP, Lambert MA, Brown DC, Kurtz AB, Cotton PB, Russell RCG (1988) Total pan-createctomy for chronic pancreatitis. Gut 29:358 –365PubMedCrossRefGoogle Scholar
  9. 9.
    Vantini I, Lucchin L, Piubello W, Brocco G, Marchiaro G, Benini L, Cavallini G, Scuro LA (1981) In vitro comparison of enzymatic activities in 19 enzyme-containing commercial preparations marketed in Italy. Ital J Gastroenterol 13:190–192Google Scholar
  10. 10.
    Otte M, Gutowski HD, Mackenroth T (1991) In vitro testing of pancreatic enzyme preparations. In: Lankisch PG (ed) Pancreatic enzyme in health and disease. Springer, Berlin Heidelberg New York, pp 65 – 70CrossRefGoogle Scholar
  11. 11.
    Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP (1987) Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child 62:564–568PubMedCrossRefGoogle Scholar
  12. 12.
    Ruyssen R, Lauwers A (1978) Pharmaceutical enzymes. Story Scientia, Gent, pp 57–84Google Scholar
  13. 13.
    Reynolds JEF (1989) Martindale. The extra pharmacopoeia, 29th edn. Pharmaceutical Press, LondonGoogle Scholar
  14. 14.
    Thiruvengadam R, Di Magno EP (1988) Inactivation of human lipase by proteases. Am J Physiol 255 : G476 – G481PubMedGoogle Scholar
  15. 15.
    Pap A, Varro V (1986) Replacement therapy in pancreatic insufficiency with a new pan-creatin preparation as the cause of the excellent results of replacement therapy. Dig Dis Sci 31:519CrossRefGoogle Scholar
  16. 16.
    Pap A, Varro V (1988) Replacement therapy in pancreatic insufficiency with a new pan-creatin preparation respecting the physiological ratio of lipase/trypsin activity. Hepato-gastroenterology 35:83 – 86PubMedGoogle Scholar
  17. 17.
    Slaff J, Jacobs D, Tillman CR, Currington C, Toskes P (1984) Protease specific suppression of pancreatic exocrine secretion. Gastroenterology 87:44–52PubMedGoogle Scholar
  18. 18.
    Lankisch PG (1991) Differential treatment of exocrine pancreatic insufficiency in chronic pancreatitis. In: Lankisch PG (ed) Pancreatic enzymes in health and disease. Springer, Berlin Heidelberg New York, pp 191–208CrossRefGoogle Scholar
  19. 19.
    Halgreen H, Thorsgaard Pedersen N, Worning H (1986) Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis. Scand J Gastroenterol 21:104 –108PubMedCrossRefGoogle Scholar
  20. 20.
    Isaksson G, Ishe I (1983) Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 28:97 –102PubMedCrossRefGoogle Scholar
  21. 21.
    Slaff J, Jacobson D, Tillman CR, Curington C, Toskes P (1984) Protease specific suppression of pancreatic secretion. Gastroenterology 87:44 –52PubMedGoogle Scholar
  22. 22.
    Malesci A, Gaia E, Vantini I, Bocchia P, Fioretta A, Ciravegna CP (1990) Effect of pancreatic extract therapy on abdominal pain in chronic pancreatitis: a 4 months double blind crossover study. Gastroenterology 5 : A 228Google Scholar
  23. 23.
    Mössner J, Secknus R, Meyer J, Niederau C, Adler G (1991) Treatment of pain with pancreatic extracts in chronic pancreatitis. Gastroenterology 100 : A290Google Scholar
  24. 24.
    Di Magno EP, Go VLW, Summerskill WHJ (1973) Relation between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 288:813–815CrossRefGoogle Scholar
  25. 25.
    Lankisch PG, Lembke B, Wemken G, Creutzfeldt W (1986) Functional reserve capacity of the exocrine pancreas. Digestion 35:175 –181PubMedCrossRefGoogle Scholar
  26. 26.
    Gaskin KJ, Durie PR, Lee L, Durie PR (1984) Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Gastroenterology 86:1–7PubMedGoogle Scholar
  27. 27.
    Zerega J, Lerner S, Meyer H (1988) Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency. Dig Dis Sci 33:1245–1249PubMedCrossRefGoogle Scholar
  28. 28.
    Kelly DG, Sandberg RJ, Bentley KJ, Zinsmeister AR, Di Magno EP (1988) Protection of lipolytic activity by nutrients in simulated pancreatic insufficiency. Pancreas 3:601Google Scholar
  29. 29.
    Dekehart MR, Dutta SK, Vaeth J (1989) Dietary fiber supplementation: effect on exocrine pancreatic secretion in man. Am J Clin Nutr 50:1023 –1028Google Scholar
  30. 30.
    Dutta SK, Hlasko J, (1985) Dietary fiber in pancreatic disease: effect of high fiber diet on fat malabsorption in pancreatic insufficiency and in vitro study of the interaction of dietary fiber with pancreatic enzymes. Am J Clin Nutr 41:517–525PubMedGoogle Scholar
  31. 31.
    Gullo L, Pezzilli R, Cassano A, Ligabue A, Ventrucci M, Barbara L (1988) Clinical effectiveness of a new enteric-coated pancreatic enzyme extract in the treatment of the pancreatic steatorrhea. Curr Ther Res 44:105 –109Google Scholar
  32. 32.
    Fioretta A, Bonfante F, Caliari S, Brentegani MT, Scattolini C, Benini L, Vantini I (1992) Effect of a new pancreatic supplement (enteric-coated microtablets) with a very high lipase content on faecal fat excretion in patients with exocrine pancreatic insufficiency. Ital J Gastroenterol 24:160Google Scholar
  33. 33.
    Elashoff J, Porter-Fink V, Dressman J, Amidon G (1987) What should be the size of pancreatin microspheres? Gastroenterology 92:1533Google Scholar
  34. 34.
    Vantini I, Fioretta A, Brocco G, Benini L, Sembenini C, Scuro LA (1987) Attività nel lume duodenale di un nuovo preparato contenente enzimi pancreatici. Ter Mod 4:145–150Google Scholar
  35. 35.
    Dutta SK, Rubin J, Jeffrey H (1983) Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology 84:476–482PubMedGoogle Scholar
  36. 36.
    Regan PT, Malagelada JR, Di Magno EP, Go VLW (1979) Postprandial gastric function in pancreatic insufficiency. Gut 20:249 – 254PubMedCrossRefGoogle Scholar
  37. 37.
    Cortot A, Jobin G, Ruskone A, Bernier JJ (1981) Rapid gastric emptying of lipids in pancreatic insufficiency in man. Gastroenterology 80:1129Google Scholar
  38. 38.
    Long WB, Weiss JB (1974) Rapid gastric emptying of fatty meals in pancreatic insufficiency. Gastroenterology 67:920 – 925PubMedGoogle Scholar
  39. 39.
    Meyer JH (1991) Delivery of pancreatin in microsphere preparations: transit, timing, physiological needs. In: Lankisch PG (ed) Pancreatic enzymes in health and disease. Springer, Berlin Heidelberg New York, pp 71 – 88CrossRefGoogle Scholar
  40. 40.
    Sirois PJ, Amidon GL, Meyer JH, Doty JE, Dressman JB (1990) Size and density discrimination of nondigestible solids during gastric emptying in dogs: a hydrodynamic correlation. Am J Physiol 258 : G65 – G72PubMedGoogle Scholar
  41. 41.
    Heizer WD, Cleaveland CR, Iver FL (1965) Gastric inactivation of pancreatic supplements. Bull Johns Hopkins Hosp 116:261–270PubMedGoogle Scholar
  42. 42.
    Di Magno EP (1982) Controversies in the treatment of exocrine pancreatic insufficiency. Dig Dis Sci 27:4811–484Google Scholar
  43. 43.
    Piubello W, Vantini I, Novelli P, Scuro LA, Benini L, Brocco G, Cavallini G (1982) Gastric secretion, gastroduodenal histological changes and serum gastrin in chronic alcoholic pancreatitis. Am J Gastroenterol 77:105–110PubMedGoogle Scholar
  44. 44.
    Saunders JHB, Cargill JM, Worsmley KG (1978) Gastric secretion of acid in patients with pancreatic disease. Digestion 17:365–369PubMedCrossRefGoogle Scholar
  45. 45.
    Ovensen L, Bendtsen F, Tage-Jensen U, Pedersen NT, Gram BR, Rune SJ (1986) Intraluminal pH in the stomach, duodenum and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. Gastroenterology 90:958–962Google Scholar
  46. 46.
    Dutta SK, Russell RM, Iber FI (1979) Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine. Dig Dis Sci 24:529–534PubMedCrossRefGoogle Scholar
  47. 47.
    Dutta SK, Russell RM, Iber FI (1979) Impaired acid neutralization in the duodenum in pancreatic insufficiency. Dig Dis Sci 44:775–780CrossRefGoogle Scholar
  48. 48.
    Zentler-Munro PL, Fine DR, Batten JC, Northfield TC (1985) Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilization in pancreatic steatorrhea due to cystic fibrosis. Gut 26:892–901PubMedCrossRefGoogle Scholar
  49. 49.
    Younberger CA, Berardi RR, Howatt WF, Hyneck ML, Amidon GL, Meyer JH, Dressman JB (1987) Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. Dig Dis Sci 32:472–480CrossRefGoogle Scholar
  50. 50.
    Regan PT, Malagelada JR, Go VLW (1976) Use of cimetidine with oral pancreatic replacement in cystic fibrosis. Clin Res 24:567Google Scholar
  51. 51.
    Regan PT, Malagelada JR, Di Magno EP, Glanzman SL, Go VLW (1977) Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 297:854–858PubMedCrossRefGoogle Scholar
  52. 52.
    Regan PT, Malagelada JR, Di Magno EP, Go VLW (1978) Rationale for use of cimetidine in pancreatic insufficiency. Mayo Clin Proc 53:79–83PubMedGoogle Scholar
  53. 53.
    Gow R, Bradbear R, Francis P, Shepherd R (1981) Comparative study of varying regimens to improve steatorrhoea and creatorrhoea un cystic fibrosis: effectiveness of an enteric-coated preparation with and without antacid and cimetidine. Lancet 2:1071–1074PubMedCrossRefGoogle Scholar
  54. 54.
    Lankisch PG, Lembcke B, Goke B, Creutzfeldt W (1983) Therapy of pancreatogenic steatorrhea: does acid protection of pancreatogenic enzymes offer any advantages? Digestion 28:43Google Scholar
  55. 55.
    Boyle BJ, Long WB, Balistrieri WF, Widzer SJ, Huang N (1980) Effect of cimetidine and pancreatic enzymes on serum and faecal bile acids and fat absorption in cystic fibrosis. Gastroenterology 78:950 – 953PubMedGoogle Scholar
  56. 56.
    Gullo L, Corinaldesi R, Casadio R (1983) Gastric acid secretion in chronic pancreatitis. Hepatogastroenterology 30:60 – 62Google Scholar
  57. 57.
    Bianchi Porro G, Dolcini R, Grossi E, Petrillo M, Prada A (1977) Cimetidine in treatment of pancreatic insufficiency. Lancet 2:878 – 879PubMedCrossRefGoogle Scholar
  58. 58.
    Lamers CBHW (1986) Omeprazole as adjunct to enzyme replacement treatment in severe pancreatic insufficiency. Br Med J 239:994CrossRefGoogle Scholar
  59. 59.
    Dutta SK, Hubbard VS, Appier M (1988) Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in the treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis. Dig Dis Sci 33:1237–1244PubMedCrossRefGoogle Scholar
  60. 60.
    Guarner L, Rodriguez R, Malagelada JR (1989) Ileal vs. duodenal enzyme activities in treated and untreated pancreatic steatorrhea. Gastroenterology 96: A187Google Scholar
  61. 61.
    Schneider MU, Knoll-Ruzicka ML, Domschke S, Heptner G, Domschke W (1985) Pancreatic enzyme replacement therapy: comparative effects of conventional enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhea in chronic pancreatitis. Hepatogastroenterology 32:97–102PubMedGoogle Scholar
  62. 62.
    Vantini I, Fioretta A, Caliari S, Benini L, Brentegani MT, Castellani G, Bonfante F (1990) Effects of two pancreatic enzyme-containing enteric-coated microsphere preparations on steatorrhea in chronic alcoholic pancreatitis. Curr Ther Res 48:1 – 7Google Scholar
  63. 63.
    Mitchell EA, Quested C, Marks ER (1987) Comparative trial of Viokase, pancreatin and Pancrease pancrealipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis. Aust Pediatr J 42:114–117Google Scholar
  64. 64.
    Stead RJ, Skypala I, Hodson ME, Batten JC (1987) Enteric-coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric-coated preparation. Thorax 42:533–537PubMedCrossRefGoogle Scholar
  65. 65.
    Braggion C, Borgo G, Faggionato P, Mastella G (1987) Influence of antacid and formulation on effectiveness of pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child 62:349–356PubMedCrossRefGoogle Scholar
  66. 66.
    Chazalette JP, Dain MP, Castaigne JP (1988) Efficacy of Pancrease. Crossover comparative study versus Eurobiol in cystic fibrosis. J Pediatr Gastroenterol Nutr 7:46–48CrossRefGoogle Scholar
  67. 67.
    Bouquet J, Sinaasappel M, Neijens HJ (1988) Malabsorption in cystic fibrosis: mechanism and treatment. J Pediatr Gastroenterol Nutr 7:30–35CrossRefGoogle Scholar
  68. 68.
    Ansaldi-Balocco N, Santini B, Sarchi C (1988) Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study of the same patients at two different ages. J Pediatr Gastroenterol Nutr 7:40 –45CrossRefGoogle Scholar
  69. 69.
    Littlewood JM, Kelleher J, Walters MP, Johnson AW (1988) In vivo and in vitro studies of microsphere pancreatic supplements. J Pediatr Gastroenterol Nutr 7:22–29CrossRefGoogle Scholar
  70. 70.
    Carroccio A, Pardo F, Montalto G et al. (1988) Effectiveness of enteric-coated preparations on nutritional parameters in cystic fibrosis. A long term comparative study. Digestion 41:201–206PubMedCrossRefGoogle Scholar
  71. 71.
    Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP (1987) Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child 62:564–568PubMedCrossRefGoogle Scholar
  72. 72.
    Dobrilla G, Bonoldi MC, Chilovi F (1980) Effect of cimetidine on pancreatic function and disease. In: Torsoli A, Lucchelli PE, Brimblecombe RW (eds) Further experience with H2-receptor antagonists in peptic ulcer disease and progess in histamine research. Ex-cerpta Medica, Amsterdam, pp 148–161Google Scholar
  73. 73.
    Staub JL, Sarles H, Soule JC, Galmiche JP, Caprow JP (1981) No effect of cimetidine on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 304:1364–1365PubMedGoogle Scholar
  74. 74.
    Graham DY (1982) Pancreatic enzyme replacement: effect of antacids or cimetidine. Dig Dis Sci 27:485–490PubMedCrossRefGoogle Scholar
  75. 75.
    Scuro LA, Vantini I (1987) Nutritional problems and support in chronic pancreatitis. In: Barbara L (ed) Nutrition and gastrointestinal disease. Raven, New York, pp 273–283Google Scholar
  76. 76.
    Carroccio A, Pardo F, Montalto G, Iapichino L, Soresi M, Averna MR, Iacono G, Notarbar-tolo A (1992) Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy. A long-term study in cystic fibrosis. Dig Dis Sci 37:1441–1446PubMedCrossRefGoogle Scholar
  77. 77.
    Worning H (1980) The effect of enzyme substitution in patients with pancreatic insufficiency. Scand J Gastroenterol 15:529–533PubMedCrossRefGoogle Scholar
  78. 78.
    Braga M, Cristallo M, De Franchis R, Mangiagalli A, Agape D, Primignani M, Di Carlo V (1988) Correction of malnutrition and maldigestion with enzyme supplementation in patients with surgical suppression of exocrine pancreatic function. Surg Gynecol Obstet 167:485–492PubMedGoogle Scholar
  79. 79.
    Braga M, Cristallo M, De Franchis R, Mangiagalli A, Zerbi A, Agape D, Primignani M, Di Carlo V (1989) Pancreatic enzyme replacement therapy in postpancreatectomy patients. Int J Pancreatol 5:37–44PubMedGoogle Scholar
  80. 80.
    Domschke S (1991) Trattamento della steatorrea pancreatica, resistente alia terapia enzimatica sostitutiva convenzionale. In: Dobrilla G, De Pretis G, Piazzi L (eds) Non-responders in gastroenterologia: cause e trattamento. Cortina, Verona, pp 235 – 244Google Scholar
  81. 81.
    Armbrecht U, Lundell L, Lindstedt G, Stockbrugger RW (1988) The causes of nutrient malassimilation after total gastrectomy with Roux-en-Y reconstruction. Acta Chir Scand 154:37–41PubMedGoogle Scholar
  82. 82.
    D’Orazio C, Pederzini F, Fratton M, Crema C, Perobelli S, Mastella G (1992) Fattibilità della supplementazione nutrizionale con gastrostomia in fibrosi cistica. In: Bosco A (ed) Atti, P93Google Scholar
  83. 83.
    Silk DBA (1986) Diet formulation and choice of enterai diet. Gut 27:40– 46PubMedCrossRefGoogle Scholar
  84. 84.
    Cristallo M (1986) L’ alimentazione enterale spéciale nelle pancreatiti croniche. Schede Inform 2 :119-122Google Scholar
  85. 85.
    Dutta SK, Narang A, Nasrallah SM, Iber FL (1981) Evaluation of the efficacy of elemental diet therapy in patients with chronic alcoholic pancreatitis. Gastroenterology 84:1130Google Scholar
  86. 86.
    Kornowski A, Cosnes J, Gendre JP, Quintrec Y (1992) Enterai nutrition in malnutrition following gastric resection and cephalic pancreaticoduodenectomy. Hepatogastroenterol 39:9–13Google Scholar
  87. 87.
    Durie PR, Newth CJ, Forstner GG, Gall DG (1980) Malabsorption of medium-chian triglycérides in infants with cystic fibrosis: correction with pancreatic enzyme supplements. JPediatr 96:862–864CrossRefGoogle Scholar
  88. 88.
    Di Carlo V, Chiesa R (1984) Intraductal injection of neoprene to suppress pancreatic exocrine secretion in humans. Clinical and metabolic evaluation. Transplant Proc 16: 736–738Google Scholar
  89. 89.
    Jeejeebhoy KN, Ahmad A, Kozak G (1970) Determination of fecal fats containing both medium and long chain triglycerides and fatty acids. Clin Biochem 3:157–163PubMedGoogle Scholar
  90. 90.
    Caliari S, Benini L, Brentegani MT, Bonfante F, Castellani G, Fioretta A, Bardelli E, Vantini I (1992) Medium chain triglycerides in exocrine pancreatic insufficiency: evaluation of absorption by chemical methods. Gut 33:22Google Scholar
  91. 91.
    Griffin SM, Alderson D, Farndon JR (1989) Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs. Gut 30:1012–1015PubMedCrossRefGoogle Scholar
  92. 92.
    Zentler-Munro PL, Assoufi BA, Balasubramanjan K, Cornell S, Benoliel D, Northfield TC, Hodson ME (1992) Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhea due to cystic fibrosis. Pancreas 7:311–319 (1992)PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • I. Vantini
  • L. Benini
  • S. Caliari
  • A. Fioretta

There are no affiliations available

Personalised recommendations